Dr. Theodore Lemuel Mathuram, PhD - Nova Southeastern University - Research Associate

Dr. Theodore Lemuel Mathuram

PhD

Nova Southeastern University

Research Associate

Davie, Florida | United States

Main Specialties: Biotechnology, Oncology

Additional Specialties: Toxicology, Cancer Drug screening

Dr. Theodore Lemuel Mathuram, PhD - Nova Southeastern University - Research Associate

Dr. Theodore Lemuel Mathuram

PhD

Introduction

Primary Affiliation: Nova Southeastern University - Davie, Florida , United States

Specialties:

Additional Specialties:

Research Interests:

Education

Oct 2017
University of Madras
Ph.D in Life Sciences - Biotechnology
Apr 2011
Joseph Eye Hospital
Microbiology Observer
Observership Program
Dec 2010
University of Madras
Post Graduate diploma in Stem cell Technology and Tissue Engineering
Dec 2008
Royal Melbourne Institute of Technology
M.S Biotechnology
Dec 2006
Bishop Heber College
Diploma in Bioanalytical Techniques
Jun 2006
Bishop Heber College
B.S Zoology

Experience

Sep 2018
Research Associate
Post-Doctoral Researcher
Nova Southeastern University
Feb 2016
Junior Research Fellow (DBT-India)
Researcher
Award (Frontier Lifeline Hospital)
May 2012
Lecturer
Physiology, Biochemistry
Position (Frontier Lifeline Hospital)

Publications

4Publications

119Reads

9Profile Views

3PubMed Central Citations

GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib.

Drug Res (Stuttg) 2018 Aug 31;68(8):436-443. Epub 2018 Jan 31.

Department of Cardiothoracic Surgery, Frontier Lifeline Hospital, Chennai, Tamil Nadu, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0044-100186DOI Listing
August 2018
22 Reads

Correlative Studies Unravelling the Possible Mechanism of Cell Death in Tideglusib-Treated Human Ovarian Teratocarcinoma-Derived PA-1 Cells.

J Environ Pathol Toxicol Oncol 2017 ;36(4):321-344

Department of Cardiothoracic Surgery, Frontier Lifeline Hospital, Chennai-600101, Tamil Nadu, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1615/JEnvironPatholToxicolOncol.2017025018DOI Listing
February 2018
18 Reads
0.880 Impact Factor

Copper oxide nanoparticles induce anticancer activity in A549 lung cancer cells by inhibition of histone deacetylase.

Biotechnol Lett 2018 Feb 7;40(2):249-256. Epub 2017 Nov 7.

Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, 620 024, Tamil Nadu, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10529-017-2463-6DOI Listing
February 2018
30 Reads
1.591 Impact Factor

Tideglusib induces apoptosis in human neuroblastoma IMR32 cells, provoking sub-G0/G1 accumulation and ROS generation.

Environ Toxicol Pharmacol 2016 Sep 20;46:194-205. Epub 2016 Jul 20.

Department of Cardiothoracic Surgery, Frontier Lifeline Hospital, Chennai 600101, Tamil Nadu, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.etap.2016.07.013DOI Listing
September 2016
49 Reads
3 Citations
1.862 Impact Factor